二甲双胍相关乳酸酸中毒合并急性肾损伤:法国多中心观察性研究结果
该法国多中心回顾性研究纳入2015年因急性肾损伤(AKI)背景下发生乳酸酸中毒(LA)的接受二甲双胍治疗的糖尿病患者173例(MILA 109例、MALA 64例),联系了126个肾内科单位和23个ICU。103例无血流动力学不稳定(MILA 82例、MALA 21例),70例休克(含MILA 27例);休克与死亡相关(OR 12.92,p<.001)。消化道症状与MILA强相关(p=.0001),MALA与休克显著相关(p<.0001)。MALA死亡率26%高于MILA的7%。133例接受透析,透析与休克、血钾、乳酸和血肌酐水平显著相关;多因素分析中仅MILA患者二甲双胍水平与pH或乳酸水平独立相关。
要点
- 173例二甲双胍使用者AKI背景下发生LA:MILA 109例、MALA 64例;MALA死亡率26%高于MILA的7%。
- 70例休克(含MILA 27例),休克与死亡相关(OR 12.92,p<.001);MALA与休克显著相关(p<.0001)。
- 消化道症状与MILA强相关(p=.0001);MALA患者更常出现休克,死亡与基础病相关、二甲双胍蓄积加重LA。
- 133例接受透析,透析与休克、血钾、乳酸和血肌酐水平显著相关。
- 多因素分析中,仅MILA患者二甲双胍水平与pH或乳酸水平独立相关。
适用人群与场景
- 接受二甲双胍治疗的糖尿病患者,在急性肾损伤背景下发生乳酸酸中毒;来自法国126个肾内科单位和23个ICU的2015年病例。
- MILA定义为除二甲双胍蓄积外未发现其他导致乳酸酸中毒的情况;MALA为二甲双胍相关乳酸酸中毒。
- 按有无血流动力学不稳定分为无休克103例(MILA 82例、MALA 21例)与休克70例(含MILA 27例)。
诊断标准与关键阈值
- MILA:除二甲双胍蓄积外未发现其他导致乳酸酸中毒的情况;MALA为二甲双胍相关乳酸酸中毒。
- 急性肾损伤背景下发生乳酸酸中毒为纳入前提。
红旗征与不能漏的情况
- 休克:与死亡相关(OR 12.92,p<.001),MALA与休克显著相关(p<.0001)。
- MALA患者更常出现休克,死亡与基础病相关。
- MILA死亡归因于严重难治性酸中毒导致心血管崩溃,主要因AKI致二甲双胍蓄积。
研究设计与关键结果
- 法国多中心回顾性研究,纳入173例(MILA 109例、MALA 64例),联系126个肾内科单位和23个ICU。
- 103例无血流动力学不稳定(MILA 82例、MALA 21例),70例休克(含MILA 27例);休克与死亡相关(OR 12.92,p<.001)。
- 消化道症状与MILA强相关(p=.0001);MALA与休克显著相关(p<.0001)。
- MALA死亡率26%,高于MILA的7%。
- 133例接受透析,透析与休克、血钾、乳酸和血肌酐水平显著相关。
- 多因素分析中,二甲双胍水平仅与MILA患者的pH或乳酸水平独立相关。
证据类型、等级与局限
- 证据类型:法国多中心回顾性观察性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在二甲双胍使用者合并AKI和乳酸酸中毒时,需区分MILA与MALA:MILA多伴消化道症状、死亡归因于二甲双胍蓄积所致难治性酸中毒和心血管崩溃;MALA更常休克、死亡与基础病相关。
- 休克与死亡相关(OR 12.92,p<.001),MALA与休克显著相关(p<.0001),床旁需识别休克状态。
- 133例接受透析,透析与休克、血钾、乳酸和血肌酐水平显著相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Background: Metformin-associated lactic acidosis (MALA) and metformin-induced lactic acidosis (MILA) remain controversial entities. Metformin toxic effect depends on accumulation to lead to lactic acidosis (LA), particularly during an episode of acute kidney injury (AKI). In MILA, no other condition contributing to LA is found. The aims of this study were to describe the characteristics and prognosis of AKI associated with LA in metformin users and to clarify the role of this drug in the different types of LA.Methods: We performed a French multicenter retrospective study in diabetic patients treated by metformin presenting with LA in a context of AKI in 2015. 126 nephrology units (NU) and 23 intensive care units (ICU) were contacted. We individualized MILA and MALA patients in order to illustrate the role of metformin.Results: We included 173 patients (109 MILA, 64 MALA). 103 patients presented without hemodynamic instability (82 MILA and 21 MALA) whereas 70 patients were shocked including 27 MILA. The shock was associated with death with an odds ratio (OR) of 12.92 (p < .001). Digestive disorders (DD) were strongly associated with MILA (p = .0001). MALA was significantly associated with shock (p < .0001). The mortality rate was higher in MALA (26%) when compared with MILA (7%). Dialysis performed in 133 patients was significantly associated with shock, kalemia, lactate and serum creatinine levels. In multivariate analysis, metformin level was independently associated with pH or lactate level only in MILA patients.Conclusions: MILA is associated with DD and death is due to severe refractory acidosis leading to cardiovascular collapse attributed to metformin accumulation mainly via AKI. MALA patients are more frequently shocked and death is related to their underlying condition, metformin accumulation increasing LA.
参考来源
- Corchia A, Wynckel A, Journet J, et al. Metformin-related lactic acidosis with acute kidney injury: results of a French observational multicenter study. Clin Toxicol (Phila). 2019. PMID: 31387415. doi:10.1080/15563650.2019.1648816
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。